Evoke plc (LON:EVOK – Get Free Report)’s stock price was down 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
Several research firms have commented on EVOK. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank lowered their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th.
View Our Latest Stock Analysis on Evoke
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Analysts anticipate that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling
In related news, insider Andrea Gisle Joosen bought 14,572 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by insiders.
About Evoke
Recommended Stories
- Five stocks we like better than Evoke
- Growth Stocks: What They Are, Examples and How to Invest
- MarketBeat Week in Review – 03/24 – 03/28
- Stock Analyst Ratings and Canadian Analyst Ratings
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What is diluted earnings per share (Diluted EPS)?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.